New vaccine combo aims to stop pancreatic cancer return after surgery
Disease control
Recruiting now
This study tests a personalized cancer vaccine (XH001) given after surgery for pancreatic cancer, followed by immunotherapy drugs (ipilimumab, sintilimab) and chemotherapy (gemcitabine + capecitabine). The goal is to see if this combination can prevent the cancer from coming back…
Phase: NA • Sponsor: Wu Wenming • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC